- Report
- November 2021
- 545 Pages
Global
From €3641EUR$4,000USD£3,092GBP
- Report
- November 2021
- 233 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- November 2021
- 1165 Pages
Global
From €5461EUR$6,000USD£4,638GBP
- Book
- April 2022
- 400 Pages
- Book
- January 2022
- 336 Pages
- Book
- November 2008
- 496 Pages
The genotyping market is a subset of the genomics industry that focuses on the identification of genetic variations between individuals. It is used to identify genetic markers associated with diseases, to determine the risk of developing certain conditions, and to identify the most effective treatments for a given individual. Genotyping is also used in the development of personalized medicine, which is tailored to the individual’s genetic makeup. Genotyping technologies include next-generation sequencing, microarrays, and PCR-based methods.
The genotyping market is expected to grow due to the increasing demand for personalized medicine, the development of new technologies, and the increasing availability of genomic data. Additionally, the increasing prevalence of chronic diseases and the need for more accurate diagnosis and treatment are expected to drive the growth of the genotyping market.
Some companies in the genotyping market include Illumina, Thermo Fisher Scientific, BGI, Agilent Technologies, and PerkinElmer. Show Less Read more